{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:33Z","timestamp":1793214633614,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ajo.2005.11.050","type":"journal-article","created":{"date-parts":[[2006,3,29]],"date-time":"2006-03-29T07:13:09Z","timestamp":1143616389000},"page":"629-629.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Cataract Formation and Other Complications of Intravitreal Triamcinolone for Macular Edema"],"prefix":"10.1016","volume":"141","author":[{"given":"John T.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2005.11.050_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0002-9394(80)90239-1","article-title":"Inhibition of intraocular proliferations with intravitreal corticosteroids","volume":"89","author":"Tano","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9394(81)90013-1","article-title":"The lack of toxicity of intravitreally administered triamcinolone acetonide","volume":"91","author":"McCuen","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","article-title":"Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations","volume":"101","author":"Hida","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age-related macular degeneration","volume":"20","author":"Danis","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2005.11.050_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","article-title":"Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis","volume":"29","author":"Young","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitic cystoid macular edema","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema","volume":"132","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bjo.86.2.247","article-title":"Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion","volume":"86","author":"Greenberg","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib10","first-page":"1217","article-title":"Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion","volume":"120","author":"Ip","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00417-002-0529-0","article-title":"Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion","volume":"240","author":"Jonas","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.88.1.154","article-title":"Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion","volume":"88","author":"Chen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/112067210501500115","article-title":"The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion","volume":"15","author":"Ozkiris","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema","volume":"29","author":"Conway","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajo.2005.11.050_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","article-title":"Intravitreal triamcinolone for refractory pseudophakic macular edema","volume":"135","author":"Benhamou","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","article-title":"Combined photodynamic therapy with verteporfin and intravitreal triamcinolone for choroidal neovascularization","volume":"110","author":"Spaide","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.2003.027177","article-title":"Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degeneration","volume":"88","author":"Rechtman","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","article-title":"Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide","author":"Jonas","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/archopht.121.2.271","article-title":"Endophthalmitis caused by Mycobacterium chelonae abscesses after intravitreal injection triamcinolone","volume":"121","author":"Benz","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/archopht.121.9.1279","article-title":"Noninfectious endophthalmitis associated with intravitreal triamcinolone injection","author":"Roth","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","article-title":"Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection","volume":"23","author":"Nelson","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2005.11.050_bib24","first-page":"758","article-title":"Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion","volume":"137","author":"Kaushik","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00061198-200406000-00016","article-title":"Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide","volume":"13","author":"Jonas","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2005.11.050_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bjo.2003.033589","article-title":"Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema","volume":"88","author":"Chen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/archopht.122.7.1083-a","article-title":"Safety and efficacy of intravitreal triamcinolone","volume":"122","author":"Savage","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib28","first-page":"45","article-title":"Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide","volume":"292","author":"Detry-Morel","year":"2004","journal-title":"Bull Soc Belge Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ajo.2004.03.001","article-title":"Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection","volume":"138","author":"Singh","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00347-004-1074-5","article-title":"Diffuse diabetic macular edema","volume":"102","author":"Kreissig","year":"2005","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ajo.2005.11.050_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajo.2004.03.025","article-title":"Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema","volume":"138","author":"Moshfeghi","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajo.2004.05.031","article-title":"Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide","volume":"138","author":"Agrawal","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0420.2005.00379.x","article-title":"Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema","volume":"83","author":"Imasawa","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2005.11.050_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.1989.01070020053028","article-title":"Lens Opacity Classification System II (LOCS II)","volume":"107","author":"Chylack","year":"1989","journal-title":"Arch Opthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0002-9394(00)00732-7","article-title":"The Age-Related Eye Disease Study (AREDS) system for classifying cataract from photographs","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00347-003-0862-7","article-title":"Intraocular trismcinolone for diffuse diabetic macular edema","volume":"101","author":"Degenring","year":"2004","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ajo.2005.11.050_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2004.02.025","article-title":"Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema","volume":"138","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.eye.6701512","article-title":"Intravitreal triamcinolone as a primary therapy in diabetic macular oedema","volume":"19","author":"Karacorlu","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2005.11.050_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/112067210401400407","article-title":"Intravitreal triamcinolone acetonide","volume":"14","author":"Micelli Ferrari","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib43","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates","volume":"88","author":"Ciardella","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib44","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ophtha.2004.05.025","article-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment","volume":"111","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1442-9071.2004.00903.x","article-title":"Intravitreal triamcinolone for diabetic macular oedema in Chinese patients","volume":"32","author":"Lam","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib46","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajo.2004.07.007","article-title":"Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide","volume":"138","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/112067210401400615","article-title":"Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema","volume":"14","author":"Ozirikis","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib48","first-page":"1012","article-title":"Diode laser, vitrectomy and intravitreal triamcinolone","volume":"19","author":"Parolini","year":"2004","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0008-4182(04)80069-3","article-title":"Intravitreal triamcinolone injection for diabetic macular edema","volume":"39","author":"Bakri","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0420.2004.00336.x","article-title":"Intravitreal triamcinolone for macular oedema","volume":"83","author":"Sorensen","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2005.11.050_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bjo.2004.046391","article-title":"Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide","volume":"89","author":"Jonas","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/soph.18.2.67.15860","article-title":"Treatment of central retinal vein occlusion with triamcinolone acetonide","volume":"18","author":"Ip","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib54","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.122.8.1137","article-title":"Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion","volume":"122","author":"Bashshur","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0420.2005.00400.x","article-title":"Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion","volume":"83","author":"Kepler","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2005.11.050_bib57","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/15428877-20050101-04","article-title":"Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide","volume":"36","author":"Yepremyan","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.ajo.2005.11.050_bib58","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9394(03)00266-6","article-title":"Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema","author":"Scott","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2005.11.050_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/112067210501500114","article-title":"Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema","volume":"15","author":"Boscia","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","article-title":"Intraocular availability of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib62","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib63","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/archopht.121.11.1663-a","article-title":"Endophthalmitis after intravitreal injection of triamcinolone acetonide","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib64","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/bjo.87.8.972","article-title":"Pseudo-endophthalmitis after intravitreal injection of triamcinolone","volume":"87","author":"Sutter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib65","doi-asserted-by":"crossref","unstructured":"Gillies MC, Simpson JM, Billson FA, et al. Safety of intravitreal injection of triamcinolone. Arch Ophthalmol 122:336\u2013340.","DOI":"10.1001\/archopht.122.3.336"},{"key":"10.1016\/j.ajo.2005.11.050_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2004.07.017","article-title":"Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract","volume":"112","author":"Gillies","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.11.050_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajo.2003.09.020","article-title":"The role of patient age and intraocular gas use in cataract progression following vitrectomy for macular holes and epiretinal membranes","volume":"137","author":"Thompson","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.11.050_bib68","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ajo.2005.01.022","article-title":"Cataract progression after intravitreal triamcinolone injection","volume":"139","author":"Cekic","year":"2005","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405012766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405012766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:51:40Z","timestamp":1757595100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939405012766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0002939405012766"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2005.11.050","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cataract Formation and Other Complications of Intravitreal Triamcinolone for Macular Edema","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2005.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}